Catalyst event

Novo Nordisk A/S (NVO)

From KEDI Global Longevity Bio Index (KGLB)

Novo Nordisk’s false-advertising lawsuit against Eli Lilly was updated by Lilly’s public statement that it will defend the case vigorously.

Korean translation

노보 노디스크의 허위광고 소송에 대해 일라이 릴리가 적극적으로 방어하겠다는 입장을 공개함.